Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Direxion Daily S&P 500 Bear 3X Shares ETF
SPXS
5
ProShares UltraPro Short S&P500 ETF
SPXU
US Stock MarketDetailed Quotes
ADPT Adaptive Biotechnologies
- 9.840
- +2.480+33.70%
Close May 2 16:00 ET
- 9.860
- +0.020+0.20%
Post 20:01 ET
1.49BMarket Cap-10.36P/E (TTM)
10.280High8.570Low15.57MVolume8.810Open7.360Pre Close153.45MTurnover15.60%Turnover RatioLossP/E (Static)151.92MShares10.28052wk High7.85P/B982.14MFloat Cap2.99052wk Low--Dividend TTM99.81MShs Float71.250Historical High--Div YieldTTM23.23%Amplitude2.280Historical Low9.854Avg Price1Lot Size
Adaptive Biotechnologies News
Adaptive Biotechnologies Reports Strong Earnings and Strategic Growth
Earnings From Adaptive Biotechnologies ADPT +34% & Fulcrum FULC +28%
Small U.S. Stocks Close Up; Adaptive Biotechnologies Leads Increases
Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results
BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $11
J.P. Morgan Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $10
Sector Update: Health Care Stocks Higher Friday Afternoon
12 Health Care Stocks Moving In Friday's Intraday Session
Adaptive Biotechnologies Is Maintained at Buy by Goldman Sachs
Adaptive Biotechnologies Price Target Raised to $10.00/Share From $9.00 by Goldman Sachs
Adaptive Biotechnologies Analyst Ratings
Adaptive Biotechnologies Shares Surge After Q1 Loss Narrows, Revenue Rises
$ADPT Stock Is up 32% Today. Here's What We See in Our Data.
Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday
Adaptive Biotechnologies Shares Are Trading Higher After the Company Reported Q1 Financial Results and Beat Its EPS and Revenue Estimates.
William Blair Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating
TD Cowen Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $13
Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $11
Analysts Are Bullish on Top Healthcare Stocks: Amgen (AMGN), Adaptive Biotechnologies (ADPT)
Positive Outlook for Adaptive Biotechnologies: Strong Revenue Growth and Strategic Initiatives Support Buy Rating
Market Insights
Discussing
BRK cash at new high: What to expect from Buffett’s meeting?
🎙️Discussion 1. Buffett said he won't sell Japanese stocks for the next ten years. What's your take? 2. In the face of market changes, do y
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now